Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myositis, Inclusion Body”

61 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 61 results

Not applicableStudy completedNCT05890833
What this trial is testing

The Risk of Falls Index for Patients With Neuromuscular Disorders

Who this might be right for
Inclusion Body MyositisMyotonic DystrophyFacioscapulohumeral Muscular Dystrophies+3 more
LMU Klinikum 30
Large-scale testing (Phase 3)Study completedNCT01165008
What this trial is testing

Anakinra in Myositis

Who this might be right for
PolymyositisDermatomyositisInclusion Body Myositis
Karolinska Institutet
Post-approval studies (Phase 4)Not Yet RecruitingNCT07240649
What this trial is testing

Outcomes From Hyperbaric Oxygen (HBO2) Treatment for Emerging Indications

Who this might be right for
Post-COVID-19 ConditionUlcerative ColitisCrohn Disease+38 more
Jay C. Buckey Jr. 100
Not applicableUnknownNCT05272969
What this trial is testing

Pompe & Pain - Study to Assess Nociceptive Pain in Adult Patients With Pompe Disease

Who this might be right for
Pompe Disease (Late-onset)Inclusion Body MyositisSpinal Muscular Atrophy Type 3+1 more
LMU Klinikum 95
Large-scale testing (Phase 3)Study completedNCT02573467
What this trial is testing

An Extension Study of the Efficacy, Safety and Tolerability of BYM338 (Bimagrumab) in Patients With Sporadic Inclusion Body Myositis Who Previously Participated in the Core Study CBYM338B2203

Who this might be right for
Sporadic Inclusion Body Myositis
Novartis Pharmaceuticals 211
Not applicableStudy completedNCT01734369
What this trial is testing

Environmental Risk Factors for Myositis in Military Personnel

Who this might be right for
DermatomyositisAdult PolymyositisInclusion Body Myositis+1 more
National Institute of Environmental Health Sciences (NIEHS) 37
Testing effectiveness (Phase 2)WithdrawnNCT03710941
What this trial is testing

Safety and Efficacy of REGN2477+REGN1033 in Patients With Sporadic Inclusion Body Myositis

Who this might be right for
Sporadic Inclusion Body Myositis
Regeneron Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT02753530
What this trial is testing

Study of Arimoclomol in Inclusion Body Myositis (IBM)

Who this might be right for
Inclusion Body Myositis
ZevraDenmark 152
Not applicableEnrolling By InvitationNCT06605612
What this trial is testing

Development and Validation of the FBIndex to Determine the Risk of Falls for Patients With Neuromuscular Disorders

Who this might be right for
Inclusion Body MyositisMyotonic DystrophyLimb-girdle and Facioscapulohumeral Muscular Dystrophies+9 more
LMU Klinikum 108
Large-scale testing (Phase 3)Active Not RecruitingNCT06450886
What this trial is testing

Long-term Extension Study of Ulviprubart (ABC008) in Subjects With Inclusion Body Myositis

Who this might be right for
Inclusion Body Myositis (IBM)
Abcuro, Inc. 270
Early research (Phase 1)UnknownNCT05032131
What this trial is testing

Cell Therapy for IBM by Muscle Injection of ADSVF

Who this might be right for
Inclusion Body Myositis
Assistance Publique - Hôpitaux de Paris 32
Not applicableStudy completedNCT06644482
What this trial is testing

Exercise as Treatment for Patients With Inclusion Body Myositis

Who this might be right for
Inclusion Body Myositis (IBM)Feasibility Study
Oslo University Hospital 15
Large-scale testing (Phase 3)Ended earlyNCT04049097
What this trial is testing

Arimoclomol in Sporadic Inclusion Body Myositis - Open Label Extension Trial

Who this might be right for
Inclusion Body Myositis
ZevraDenmark 121
Large-scale testing (Phase 3)Study completedNCT00769860
What this trial is testing

Arimoclomol in Sporadic Inclusion Body Myositis

Who this might be right for
Inclusion Body Myositis
Richard Barohn, MD 24
Not applicableStudy completedNCT03633318
What this trial is testing

Establishing Muscle Impedance Parameters With Electrical Impedance Myography

Who this might be right for
IBMInclusion Body Myositis
Yale University 31
Not applicableStudy completedNCT01432613
What this trial is testing

Diagnostic Accuracy of Whole Body Magnetic Resonance Imaging in Inflammatory Myopathies

Who this might be right for
MyositisPolymyositisDermatomyositis+1 more
Assistance Publique - Hôpitaux de Paris 139
Not applicableStudy completedNCT00898989
What this trial is testing

Muscle Strength and Inflammatory Response in Patients With Inclusion Body Myositis

Who this might be right for
Inclusion Body Myositis
Institut de Myologie, France 42
Testing effectiveness (Phase 2)Study completedNCT01423110
What this trial is testing

Efficacy, Safety and Tolerability of BYM338 in Patients With Sporadic Inclusion Body Myositis

Who this might be right for
Sporadic Inclusion Body Myositis
Novartis Pharmaceuticals 14
Not applicableActive Not RecruitingNCT05046821
What this trial is testing

Sporadic Inclusion Body Myositis Natural History Study

Who this might be right for
Sporadic Inclusion Body MyositisInclusion Body Myositis
University of California, Irvine 150
Large-scale testing (Phase 3)Study completedNCT02250443
What this trial is testing

Study of Long-term Safety, Efficacy Tolerability of BYM338 in Patients With Sporadic Inclusion Body Myositis

Who this might be right for
Sporadic Inclusion Body Myositis (sIBM)
Novartis Pharmaceuticals 10
Load More Results